Toshitaka Sawamura

9PUBLICATIONS
3CO-AUTHORS
AutoimmunityTraditional Chinese medicine and treatmentsPharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)Pharmacology and pharmaceutical sciences not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 27, 2026
Acquired generalized lipodystrophy complicated by fulminant type 1 diabetes mellitus: a case report with review of literature and immunological insights.

|Feb 26, 2025
Impacts of tirzepatide on older patients with diminished β-cell function and dementia.

Toshitaka Sawamura, Shigehiro Karashima, Ai Ohmori

|Nov 29, 2024
Effects of the switch from dulaglutide to tirzepatide on glycemic control, body weight, and fatty liver: a retrospective study.

Toshitaka Sawamura, Ren Mizoguchi, Ai Ohmori

|Mar 28, 2024
Effects of Switching from Degludec to Glargine U300 in Patients with Insulin-Dependent Type 1 Diabetes: A Retrospective Study.

Toshitaka Sawamura, Shigehiro Karashima, Azusa Ohbatake

|May 04, 2023
Fulminant type 1 diabetes developed after influenza split vaccination.

Toshitaka Sawamura, Shigehiro Karashima, Ai Ohmori

|Aug 26, 2022
Hiccups as the first presentation of secondary adrenal insufficiency associated with advanced cervical cancer.

Toshitaka Sawamura, Shigehiro Karashima, Ai Ohmori

Pageof 2

Frequent Collaborators

5 joint publications

Shigehiro Karashima

4 joint publications

Mitsuhiro Kometani

3 joint publications

Takashi Yoneda